Does the temporary decrease in the estimated glomerular filtration rate (eGFR) after initiation of mineralocorticoid receptor (MR) antagonist treatment lead to a long-term renal protective effect?
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Does the temporary decrease in the estimated glomerular filtration rate (eGFR) after initiation of mineralocorticoid receptor (MR) antagonist treatment lead to a long-term renal protective effect?
Authors
Keywords
-
Journal
HYPERTENSION RESEARCH
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-09-06
DOI
10.1038/s41440-019-0320-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Creatinine Rise During Blood Pressure Therapy and the Risk of Adverse Clinical Outcomes in Patients With Type 2 Diabetes Mellitus
- (2019) Didier Collard et al. HYPERTENSION
- Mineralocorticoid receptor blockade suppresses dietary salt-induced ACEI/ARB-resistant albuminuria in non-diabetic hypertension: a sub-analysis of evaluate study
- (2019) Mitsuhiro Nishimoto et al. HYPERTENSION RESEARCH
- The Effects of eGFR Change on CVD, Renal, and Mortality Outcomes in a Hypertensive Cohort Treated With 3 Different Antihypertensive Medications
- (2018) Joshua I Barzilay et al. AMERICAN JOURNAL OF HYPERTENSION
- Cardiovascular and Renal Outcomes With Canagliflozin According to Baseline Kidney Function: Data from the CANVAS Program
- (2018) Brendon L. Neuen et al. CIRCULATION
- Renal protection by sodium-glucose cotransporter 2 inhibitors and its underlying mechanisms in diabetic kidney disease
- (2018) Akira Mima JOURNAL OF DIABETES AND ITS COMPLICATIONS
- Canagliflozin and renal outcomes in type 2 diabetes: results from the CANVAS Program randomised clinical trials
- (2018) Vlado Perkovic et al. Lancet Diabetes & Endocrinology
- Effects of Intensive BP Control in CKD
- (2017) Alfred K. Cheung et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Acute Declines in Renal Function during Intensive BP Lowering: Implications for Future ESRD Risk
- (2017) Elaine Ku et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Acute change in glomerular filtration rate with inhibition of the renin-angiotensin system does not predict subsequent renal and cardiovascular outcomes
- (2017) Catherine M. Clase et al. KIDNEY INTERNATIONAL
- Cardiovascular mortality and morbidity in patients with type 2 diabetes following initiation of sodium-glucose co-transporter-2 inhibitors versus other glucose-lowering drugs (CVD-REAL Nordic): a multinational observational analysis
- (2017) Kåre I Birkeland et al. Lancet Diabetes & Endocrinology
- Effects of empagliflozin on the urinary albumin-to-creatinine ratio in patients with type 2 diabetes and established cardiovascular disease: an exploratory analysis from the EMPA-REG OUTCOME randomised, placebo-controlled trial
- (2017) David Z I Cherney et al. Lancet Diabetes & Endocrinology
- Empagliflozin and Clinical Outcomes in Patients With Type 2 Diabetes Mellitus, Established Cardiovascular Disease, and Chronic Kidney Disease
- (2017) Christoph Wanner et al. CIRCULATION
- Mineralocorticoid receptor as a therapeutic target in chronic kidney disease and hypertension
- (2016) Shigeru Shibata et al. HYPERTENSION RESEARCH
- Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
- (2016) Christoph Wanner et al. NEW ENGLAND JOURNAL OF MEDICINE
- The necessity and effectiveness of mineralocorticoid receptor antagonist in the treatment of diabetic nephropathy
- (2015) Atsuhisa Sato HYPERTENSION RESEARCH
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
- (2015) Bernard Zinman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Characterisation of glomerular haemodynamic responses to SGLT2 inhibition in patients with type 1 diabetes and renal hyperfiltration
- (2014) Marko Škrtić et al. DIABETOLOGIA
- Aldosterone and glomerular filtration – observations in the general population
- (2014) Anke Hannemann et al. BMC Nephrology
- Anti-albuminuric effect of the aldosterone blocker eplerenone in non-diabetic hypertensive patients with albuminuria: a double-blind, randomised, placebo-controlled trial
- (2014) Katsuyuki Ando et al. Lancet Diabetes & Endocrinology
- Renal Hemodynamic Effect of Sodium-Glucose Cotransporter 2 Inhibition in Patients With Type 1 Diabetes Mellitus
- (2013) David Z.I. Cherney et al. CIRCULATION
- Incidence, Determinants, and Prognostic Significance of Hyperkalemia and Worsening Renal Function in Patients With Heart Failure Receiving the Mineralocorticoid Receptor Antagonist Eplerenone or Placebo in Addition to Optimal Medical Therapy
- (2013) Patrick Rossignol et al. Circulation-Heart Failure
- Safety and Efficacy of Eplerenone in Patients at High Risk for Hyperkalemia and/or Worsening Renal Function
- (2013) Romain Eschalier et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Glomerular Hyperfiltration and Renal Disease Progression in Type 2 Diabetes
- (2012) P. Ruggenenti et al. DIABETES CARE
- Determinants and Consequences of Renal Function Variations With Aldosterone Blocker Therapy in Heart Failure Patients After Myocardial Infarction
- (2011) Patrick Rossignol et al. CIRCULATION
- An acute fall in estimated glomerular filtration rate during treatment with losartan predicts a slower decrease in long-term renal function
- (2011) Frank A. Holtkamp et al. KIDNEY INTERNATIONAL
- Aldosterone and mineralocorticoid receptors: A personal reflection
- (2011) John W. Funder MOLECULAR AND CELLULAR ENDOCRINOLOGY
- The clinical significance of hyperfiltration in diabetes
- (2010) G. Jerums et al. DIABETOLOGIA
- Rate of Kidney Function Decline Associates with Mortality
- (2010) Z. Al-Aly et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms
- (2010) Faiez Zannad et al. NEW ENGLAND JOURNAL OF MEDICINE
- Use of Aldosterone Antagonists in Heart Failure
- (2009) Nancy M. Albert JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Change in Estimated GFR Associates with Coronary Heart Disease and Mortality
- (2009) K. Matsushita et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Mortality Risks for All Causes and Cardiovascular Diseases and Reduced GFR in a Middle-aged Working Population in Taiwan
- (2008) Ting-Yuan David Cheng et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Rapid Kidney Function Decline and Mortality Risk in Older Adults
- (2008) Dena E. Rifkin et al. ARCHIVES OF INTERNAL MEDICINE
- Risk Factors Associated with a Low Glomerular Filtration Rate in Primary Aldosteronism
- (2008) Martin Reincke et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started